Why the study?
Although the relationship between smoking and rheumatoid arthritis is confirmed, considerable regional differences exist in tobacco control implementation, prompting estimation of spatiotemporal trends in smoking-related rheumatoid arthritis burdens.
What are the spatiotemporal trends of rheumatoid arthritis burden attributable to smoking globally from 1990 to 2019?
What are the spatiotemporal trends of rheumatoid arthritis burden attributable to smoking globally from 1990 to 2019?
The global burden of rheumatoid arthritis attributable to smoking has decreased over the past 30 years, though it remains a significant issue in high-middle and high sociodemographic index regions.
This is the authors' abstract. We don't add key points for this paper.
OBJECTIVES: The relationship between smoking and RA has been confirmed. Most nations have ratified the Framework Convention on Tobacco Control. However, there are considerable regional differences in how effectively tobacco control measures were implemented. This study was carried out to estimate the spatiotemporal trends of smoking-related RA burdens. METHODS: Data were available from the Global Burden of Disease Study 2019 and were analysed by age, sex, year and region. Joinpoint regression analysis was applied to the analysis of temporal trends in the RA burden resulting from smoking over 30 years. RESULTS: From 1990 to 2019, the number of global RA cases increased each year. The age-standardized prevalence, death and disability-adjusted life-year (DALY) rates also increased. However, there was a wave in the changing trend of the age-standardized death rate, with the lowest point in 2012 and the highest point in 1990. Smoking, in particular, was responsible for 11.9% of total RA deaths and 12.8% of total DALYs in 1990 but only 8.5% of total RA deaths and 9.6% of total DALYs in 2019. A greater burden from smoking exposure was borne by men, older adults and people living in high-middle and high sociodemographic index (SDI) countries and regions. Moreover, the UK demonstrated the highest reduction in age-standardized death and DALY rates over the three decades. CONCLUSION: There were reductions in the age-standardized burdens of RA caused by smoking worldwide. Nevertheless, this continues to be an issue in some areas, and efforts to reduce smoking should be made to lessen this growing burden.
Regional disparities in smoking-related RA burden persist; extends GBD modeling but leaves open targeted policy trials.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: